Posted by Michael Wonder on 01 Mar 2021
PLx Pharma receives FDA approval of SNDAs for both Vazalore 325 mg and 81 mg
1 March 2021 - Vazalore is the first ever liquid-filled aspirin capsule with an innovative delivery platform indicated as a pain reliever, fever reducer and for aspirin therapy in vascular indications.
PLx announced today that the U.S. FDA approved supplemental new drug applications for its lead products, Vazalore 325 mg and 81 mg, the first ever novel, liquid-filled aspirin capsule.
